RareStone Group
To become the leading company in China rare disease market
25 employees · est. 2019 · China
VISEN Pharmaceuticals
Achieve better treatment processes and outcomes by combining global expertise and strength in endocrine therapies
42 employees · est. 2018 · China
VISEN Pharmaceuticals is the older company (2019 vs 2018).
Side-by-Side Comparison
| Metric | RareStone Group | VISEN Pharmaceuticals |
|---|---|---|
| Founded | ||
| Founded | 2019 | 2018 older |
| Headquarters | ||
| Headquarters | China | China |
| Employees | ||
| Employees | 25 | 42 |
| Industry | ||
| Industry | Pharmaceutical | Biotechnology, Life Sciences, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Series A | Series B |
| Total Funding | ||
| Total Funding | $80.00M | $190.00M |
| Funding Rounds | ||
| Funding Rounds | 1 | 2 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Rare Diseases, Pharmaceuticals, Healthcare Services, China Market, Therapeutic Solutions, Service Platform, Rare Disease Community, Series A Financing, Investors, Neurology, Endocrinology, AI And Big Data Analytics, Patient-centered Care, Ecosystem Development | Biopharmaceutical, Endocrine Therapies, Patient-centric Care, R&D, Pharmaceutical, Investment, Series B Financing, Innovation, Treatment Processes, Multinational, China Market, Ascendis Pharma A/S, VIVO Capital |
| Website | ||
| Website | rarestonegroup.com | visenpharma.com |
About RareStone Group
RareStone Group is on a mission to revolutionize the rare disease market in China. The company's subsidiaries, Citrine Medicine and Zircon Health, are pioneering a comprehensive ecosystem for rare diseases. Citrine Medicine focuses on delivering effective and affordable therapeutic solutions across...
About VISEN Pharmaceuticals
Visen Pharmaceuticals is an innovative biopharmaceutical company dedicated to providing innovative therapies and compassionate, patient-centric care for endocrine diseases. Their focus on endocrine diseases in adults and children, and rare endocrine diseases reflects their commitment to addressing d...
We will tell you when either one moves
BounceWatch watches RareStone Group and VISEN Pharmaceuticals for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at RareStone Group and VISEN Pharmaceuticals — by email.
Frequently Asked Questions
Compare RareStone Group with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at RareStone Group on 12 Sep 2024, and VISEN Pharmaceuticals on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.